HomeAI · summaries
Storia in 6 fonti
Novartis Drug Fails Key Test for New Heart Disease Approach
(Bloomberg) -- A Novartis AG drug billed as a potential blockbuster failed to reduce the risk of heart attacks and strokes in a final-stage trial, marking a major setback for a new approach to prevent cardiovascular disease.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
investors.com
Novartis, Ionis Tumble On Surprise Flop For Heart Drug
Novartis' Ionis-partnered Lp(a) blocker failed in testing. Both stocks fell.
- ·
swissinfo.ch
Novartis Drug Fails Key Test for New Heart Disease Approach
(Bloomberg) -- A Novartis AG drug billed as a potential blockbuster failed to reduce the risk of heart attacks and strokes in a final-stage trial, marking a major setback for a…
